Der Browser den Sie verwenden ist sehr alt.

Wir können daher nicht sicherstellen, dass jede Funktion (Gestaltung, Bilder und zusätzliche Funktionen) dieser Internetseite im vollen Umfang zur Verfügung steht. Bitte nutzen Sie eine aktuellere Browserversion.
Wir bitten um Ihr Verständnis.
Startseite > Forschung > Publikationsliste der Kinische Chemie

Publikationsliste der Klinische Chemie

2016

Kreuz W., Escuriola Ettingshausen C., Vdovin V., Zozulya N., Plyushch O., Svirin .P, Andreeva T., Bubanská E., Campos M., Benedik-Dolničar M., Jiménez-Yuste V., Kitanovski L., Klukowska A., Momot A., Osmulskaya N., Prieto M., Šalek S.Z., Velasco F., Pavlova A.,Oldenburg J., Knaub S., Jansen M., Belyanskaya L., Walter O.; ObsITI study group.; ObsITI committee. First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study. Haemophilia. 2016 Jan;22(1):87-95. doi: 10.1111/hae.12774. PubMed PMID: 26202305.

Feldkamp T., Weiler N., Marx M., Luppa P.B., Junker R. Critical deviations of ionized calcium measurements when using blood gas analyzers to monitor citrate dialysis. Clin Lab 2016;62:2025-2031, Impact-Faktor 0.936 (IF von 2015)

Arning A., Jeibmann A., Köhnemann S., Brokinkel B., Ewelt C., Berger K., Wellmann J., Nowak-Göttl U., Stummer W., Stoll M., Holling M. ADAMTS genes and the risk of cerebral aneurysm. J Neurosurg. 2016 Aug;125(2):269-74. doi: 10.3171/2015.7.JNS154.

Gersing A.S., Faymonville A.M,. Schwaiger B.J., Leypoldt F., Siemonsen S., Zimmer C., Magnus T., Fiehler J. Quantitative T2* mapping reveals early temporo-spatial dynamics in an ischemic stroke model. J. Neurosci. Methods. 2016 Feb 1;259:83-9. doi: 10.1016/j.jneumeth.2015.11.018. Epub 2015 Nov 29.

Graus F., Titulaer M.J., Balu R., Benseler S., Bien C.G., Cellucci T., Cortese I., Dale R.C., Gelfand J.M., Geschwind M., Glaser C.A., Honnorat J., Höftberger R., Iizuka T., Irani S.R., Lancaster E., Leypoldt F., Prüss H., Rae-Grant A., Reindl M., Rosenfeld M.R., Rostásy K., Saiz A., Venkatesan A., Vincent A., Wandinger K.P., Waters P., Dalmau J. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016 Apr;15(4):391-404. doi: 10.1016/S1474-4422(15)00401-9

Gövert F., Witt K., Erro R., Hellriegel H., Paschen S., Martinez-Hernandez E., Wandinger K.P., Deuschl G., Dalmau J., Leypoldt F. Orthostatic myoclonus associated with Caspr2 antibodies. Neurology. 2016 Apr 5;86(14):1353-5. doi: 10.1212/WNL.0000000000002547

Werwitzke S., Geisen U., Nowak-Göttl U., Eichler H., Stephan B., Scholz U., Holstein K., Klamroth R., Knöbl P., Huth-Kühne A., Bomke B., Tiede A. Diagnostic and Prognostic Value of Factor VIII Binding Antibodies in Acquired Hemophilia A: Data from the GTH-AH 01/2010 Study. J. Thromb. Haemost. 2016 May;14(5):940-7. doi: 10.1111/jth.13304. Epub 2016 Apr 22.

Brüggemann N., Wandinger K.P., Gaig C., Sprenger A., Junghanns K., Helmchen C., Münchau A. Dystonia, lower limb stiffness, and upward gaze palsy in a patient with IgLON5 antibodies. Mov Disord. 2016 May;31(5):762-4. doi: 10.1002/mds.26608.

Erdur H., Scholz V., Streitz M., Hammer M., Meisel C., Schönemann C., Wandinger K.P., Rosche B. EBNA1 antigen-specific CD8+ Tcells in cerebrospinal fluid of patients with multiple sclerosis. J. Neuroimmunol. 2016 May 15;294:14-7. doi: 10.1016/j.jneuroim.2016.03.010. Epub 2016 Mar 19.

Brüggemann N., Wandinger K.P., Gaig C., Sprenger A., Junghanns K., Helmchen C., Münchau A. Dystonia, lower limb stiffness, and upward gaze palsy in a patient with IgLON5 antibodies. Mov. Disord. 2016 May;31(5):762-4. doi: 10.1002/mds.26608. Epub 2016 Mar 31. No abstract available.

Kuhle J., Hardmeier M., Disanto G., Gugleta K., Ecsedi M., Lienert C., Amato M.P., Baum K., Buttmann M., Bayas A, Brassat D, Brochet B, Confavreux C, Edan G, Färkkilä M, Fredrikson S, Frontoni M., D'Hooghe M., Hutchinson M., De Keyser J., Kieseier B.C., Kümpfel T., Rio J., Polman C., Roullet E., Stolz C., Vass K., Wandinger K.P., Kappos L;. A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis.European Long-term Follow-up Study Group in Interferon β-1b in Secondary-progressive Multiple Sclerosis.. Mult Scler. 2016 Apr;22(4):533-43. doi: 10.1177/1352458515594440.

Strauss T., Elisha N., Ravid B., Rosenberg N., Lubetsky A., Levy-Mendelovich S., Morag I., Nowak Göttl U., Kenet G. Activity of Von Willebrand factor and levels of  VWF-cleaving protease (ADAMTS13) in preterm and full term neonates. Blood Cells Mol Dis. 2016 Dec 29. pii: S1079-9796(16)30161-9. doi: 10.1016/j.bcmd.2016.12.013. [Epub ahead of print] PubMed PMID: 28087247.

Neuner B, von Mackensen S, Holzhauer S, Funk S, Klamroth R, Kurnik K, Krümpel A, Halimeh S, Reinke S, Frühwald M, Nowak-Göttl U. Health-Related Quality of Life in Children and Adolescents with Hereditary Bleeding Disorders and in Children and Adolescents with Stroke: Cross-Sectional Comparison to Siblings and Peers. Biomed. Res. Int. 2016;2016:1579428. doi: 10.1155/2016/1579428. Epub 2016 May 15.

Limperger V., Kenet G., Goldenberg N.A., Heller C., Holzhauer S., Junker R., Klostermeier U.C., Knoefler R., Kurnik K., Krümpel A., Mesters R., Stach M., Young G., Nowak-Göttl U. Impact of high-risk thrombophilia status on recurrence among children with a first non-central-venous-catheter-associated VTE: an observational multicentre cohort study.  Br J Haematol. 2016 Oct;175(1):133-40. doi: 10.1111/bjh.14192

van Sonderen A., Ariño H., Petit-Pedrol M., Leypoldt F., Körtvélyessy P., Wandinger K.P., Lancaster E., Wirtz P.W., Schreurs M.W., Sillevis Smitt P.A., Graus F., Dalmau J., Titulaer M.J. The clinical spectrum of Caspr2 antibody-associated disease. Neurology. 2016 Aug 2;87(5):521-8. doi: 10.1212/WNL.0000000000002917.

Stoll M., Rühle F., Witten A., Barysenka A., Arning A., Strauss C., Nowak-Göttl U. Rare Variants in the ADAMTS13 VWF Binding Domain Contribute to Pediatric Stroke. Circ Cardiovasc Genet. 2016 Aug;9(4):357-67. doi: 10.1161/CIRCGENETICS.115.001184.

Lechner C., Baumann M., Hennes E.M., Schanda K., Marquard K., Karenfort M., Leiz S., Pohl D., Venkateswaran S., Pritsch M., Koch J., Schimmel M., Häusler M., Klein A., Blaschek A., Thiels C., Lücke T., Gruber-Sedlmayr U., Kornek B., Hahn A., Leypoldt F., Sandrieser T., Gallwitz H., Stoffels J., Korenke C., Reindl M., Rostásy K. Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease. J. Neurol. Neurosurg. Psychiatry. 2016 Aug;87(8):897-905. doi: 10.1136/jnnp-2015-311743. Epub 2015 Dec 8.

van Gerpen J.A., Ahlskog J.E., Chen R., Fung V.S., Hallett M., Gövert F., Deuschl G., Leypoldt F. Orthostatic myoclonus associated with Caspr2 antibodies. Neurology. 2016 Sep 13;87(11):1187-8. doi: 10.1212/WNL.0000000000003140.

Nowak-Göttl U., Kehrel B.E. Haemostasis - an indispensable, cross.sectional medical discipline. Thromb Haemost. 2016 Sep 27;116(4):595-6. doi: 10.1160/TH16-08-0648.

Hartmann S., Biliouris K., Lesko L..J, Nowak-Göttl U., Trame M.N. Quantitative Systems Pharmacology Model to Predict the Effect of Commonly Used Anticoagulants on the Human Coagulation Network. CPT Pharmacometrics Syst Pharmacol. 2016 Oct;5(10):554-564. doi: 10.1002/psp4.12111.

Jarius S., Ringelstein M., Haas J., Serysheva I.I., Komorowski L., Fechner K., Wandinger K.P., Albrecht P., Hefter H., Moser A., Neuen-Jacob E., Hartung H.P., Wildemann B., Aktas O. Inositol 1,4,5-trisphosphate receptor type 1 autoantibodies in paraneoplastic and non-paraneoplastic peripheral neuropathy. J Neuroinflammation. 2016 Oct 24;13(1):278.

Brüwer G., Limperger V., Kenet G., Klostermeier U.C., Shneyder M., Degenhardt F., Finckh U., Heller C., Holzhauer S., Trappe R., Kentouche K., Knoefler R., Kurnik K., Krümpel A., Lauten M., Manner D., Mesters R., Junker R., Nowak-Göttl U. Impact of high rist thrombophilia status of recurrence among children and adults with VTE: An observational multicenter cohort study. Blood Cells Mol Dis. 2016 Nov;62:24-31. doi: 10.1016/j.bcmd.2016.10.024.

Lewerenz J., Jarius S., Wildemann B., Wandinger K.P., Leypoldt F. [Autoantibody-associated autoimmune encephalitis and cerebellitis : Clinical presentation, diagnostic work-up and treatment]. Nervenarzt. 2016 Dec;87(12):1293-1299.

Finke C., Prüss H., Heine J., Reuter S., Kopp U.A., Wegner F., Then Bergh F., Koch S., Jansen O., Münte T., Deuschl G., Ruprecht K., Stöcker W., Wandinger K.P., Paul .F, Bartsch T. Evaluation of Cognitive Deficits and Structural Hippocampal Damage in Encephalitis with Leicine.Rich, Glioma-Inactivated 1 Antibodies. JAMA Neurol. 2016 Nov 21. doi: 10.1001/jamaneurol.2016.4226. [Epub ahead of print]

Nowak-Göttl U., Clausnizer H., Kowalski D., Limperger V., Krümpel A,. Shneyder M., Reinke S., Rocke A., Juhl D., Steppat D., Krause M. Health-related quality of life in children, adolescents and adults with hereditary and acquired bleeding disorders.Blood Cells Mol Dis. 2016 Nov 12. pii: S1079-9796(16)30165-6. doi: 10.1016/j.bcmd.2016.11.010. [Epub ahead of print]

Krause M., Henningsen A., Torge A., Juhl D., Junker R., Kenet G., Kowalski D., Limperger V., Mesters R., Anonymous, Rocke A., Shneyder M., Clausnizer H., Schiesewitz H., Nowak-Göttl U. Impact of gender on safty and efficacy of Rivaroxaban in adolescents & young adults with venous tromboembolism. Thromb Res. 2016 Dec;148:145-151. doi: 10.1016/j.thromres.2016.09.007.

Miske R., Gross C.C., Scharf M., Golombeck K.S., Hartwig M., Bhatia U., Schulte-Mecklenbeck A., Bönte K., Strippel C., Schöls L., Synofzik M., Lohmann H., Dettmann I.M., Deppe M., Mindorf S., Warnecke T., Denno Y., Teegen B., Probst C., Brakopp S., Wandinger K..P, Wiendl H., Stöcker W., Meuth S.G., Komorowski L., Melzer N. Neurochondrin is a neuronal target antigen in autoimmune cerebellar degeneration. Neurol Neuroimmunol Neuroinflamm. 2016 Dec 5;4(1):e307.

Nowak-Göttl U., Limperger V., Kenet G., Degenhardt .F, Arlt R., Domschikowski J.,Clausnizer H., Liebsch J., Junker R., Steppat D. Developmental hemostasis: Alifespan from neonates and pregnancy to the young and elderly adult in a Europeanwhite population. Blood Cells Mol Dis. 2016 Dec 5. pii: S1079-9796(16)30268-6.doi: 10.1016/j.bcmd.2016.11.012. [Epub ahead of print] PubMed PMID: 28017497.

Kenet G., Limperger V., Shneyder M., Nowak-Göttl U.. Risk factors for symptomaticvenous and arterial thromboembolism in newborns, children and adolescents - Whatdid we learn within the last 20years? Blood Cells Mol Dis. 2016 Dec 14. pii:S1079-9796(16)30274-1. doi: 10.1016/j.bcmd.2016.12.003. [Epub ahead of print]PubMed PMID: 28010922.
 
Rühle F., Witten A., Barysenka A., Huge A., Arning A., Heller C., Krümpel A.,Mesters R., Franke A., Lieb W., Riemenschneider M., Hiersche M., Limperger V., Nowak-Göttl U., Stoll M. Rare genetic variants in SMAP1, B3GAT2 and RIMS1contribute to pediatric venous thromboembolism. Blood. 2016 Dec 23. pii:blood-2016-07-728840. doi: 10.1182/blood-2016-07-728840. [Epub ahead of print]PubMed PMID: 28011674.

 

2015

Bietenbeck A., Junker R., Luppa P.B. Central Laboratory Service and Point-of-Care Testing in Germany – From Conflicting Notions to Complementary Understandings. Point of Care 2015;14:1-11.

Schlüter B., Junker R. Labormedizin. In: Moskopp D, Wassmann H (Hrsg.): Neurochirurgie, 2. Auflage, Schattauer 2015

Nowak-Göttl U., Limperger V., Bauer A., Kowalski D., Kenet G. Bleeding issues in neonates and infants - update 2015. Thromb Res. 2015 Feb;135 Suppl 1:S41-3. doi: 10.1016/S0049-3848(15)50440-4.

Bauer A., Limperger V., Nowak-Göttl U. End-stage renal disease and thrombophilia. Hamostaseologie. 2015 Feb 2;35(2).

Marcucci M., Mancuso M.E., Santagostino E., Kenet G., Elalfy M., Holzhauer S., Bidlingmaier C., Escuriola Ettingshausen C., Iorio A., Nowak-Göttl U. Type and intensity of FVIII exposure on inhibitor development in PUPs with haemophilia A. A patient-level meta-analysis. Thromb Haemost. 2015 May;113(5):958-67. doi: 10.1160/TH14-07-0621.

Ichord R.N., Benedict S.L., Chan A.K., Kirkham F.J., Nowak-Göttl U.; International Paediatric Stroke Study Group. Paediatric cerebral sinovenous thrombosis: findings of the International Paediatric Stroke Study. Arch Dis Child. 2015 Feb;100(2):174-9. doi: 10.1136/archdischild-2014-306382.

Klostermeier U.C., Limperger V., Kenet G., Kurnik K., Alhenc Gelas M., Finckh U.,Junker R., Heller C., Zieger B., Knöfler R., Holzhauer S., Mesters R., Krümpel A., Nowak-Göttl U. Role of protein S deficiency in children with venous thromboembolism. An observational international cohort study. Thromb Haemost. 2015 Feb;113(2):426-33. doi: 10.1160/TH14-06-0533.

Tiede A., Klamroth R., Scharf R.E., Trappe R.U., Holstein K., Huth-Kühne A., Gottstein S., Geisen U., Schenk J., Scholz U., Schilling K., Neumeister P., Miesbach W., Manner D., Greil R., von Auer C., Krause M., Leimkühler K., Kalus U., Blumtritt J.M., Werwitzke S., Budde E., Koch A., Knöbl P.. Prognostic factors for remission of and survival inacquired hemophilia A (AHA): results from the GTH-AH 01/2010 study. Blood. 2015 Feb 12;125(7):1091-7. doi: 10.1182/blood-2014-07-587089.

Graus F., Titulaer M.J., Balu R., Benseler S., Bien C.G., Cellucci T., Cortese I., Dale R.C., Gelfand J.M., Geschwind M., Glaser C.A., Honnorat J., Höftberger R., Iizuka T., Irani S.R., Lancaster E., Leypoldt F., Prüss  H., Rae-Grant A., Reindl M., Rosenfeld M.R., Rostásy K., Saiz A., Venkatesan A., Vincent A., Wandinger K.P., Waters P., Dalmau J. Clinical  Approach to Diagnosis of Autoimmune Encephalitis. Lancet Neurology, in press.

Goevert F., Witt K., Erro R., Hellriegel H., Paschen S., Martinez-Hernandez E., Wandinger K.P., Deuschl G., Dalmau J.O., Leypoldt F. Orthostatic myoclonus associated with CASPR2 antibodies. Neurology, in press.

Jarius S., Wildemann B., Stoecker W., Moser A., Wandinger, K.P. (2015) Psychotic syndrome associated with antibodies to ARHGAP26 and voltage-gated potassium channels. J. Neuroimmunol., Epub Jul 22

Kuhle J., Hardmeier M., Disanto G., Gugleta K., Ecsedi M., Lienert C., Amato M.P., Baum K., Bayas, A., Brassat D., Brochet B., Confavreux C., Edan G., Färkkilä M., Fasbender P., Fredrikson S., Frontoni M., D’Hooghe M., Hutchinson M., De Keyser J., Kieseier B.,  Kümpfel T., Laaksonen M., Rio J., Polman C., Roullet E., Vass K, Wandinger K.P., Kappos L., and the European Long Term Follow-up Study Group in Interferon β-1b in Secondary-Progressive MS. (2015) 10 year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive MS. Mult. Scler., Epub Sep 11

Lechner C., Baumann M., Hennes E.M., Schanda K., Marquard K., Karenfort M., Leiz S., Pohl D., Venkateswaran S., Pritsch M., Koch J., Schimmel M., Häusler M., Klein A., Blaschek A., Thiels C., Lücke T., Gruber-Sedlmayr U., Bajer-Kornek B., Fluss J., Hahn A., Leypoldt F., Sandrieser T., Gallwitz H., Stoffels J., Korenke J., Reindl M., Rostásy K. (2015) Antibodies to MOG and AQP4 in children with Neuromyelitis Optica and limited forms of the disease. JNNP in press.

Höftberger R., van Sonderen A., Leypoldt F., Houghton D., Geschwind M., Gelfand J., Paredes M., Sabater L., Saiz A., Titulaer M.J., Graus F., Dalmau J. (2015) Encephalitis and AMPA receptor antibodies: novel findings in a case series of 22 patients. Neurology 84 (24):2403-12. IF 8.303

Finke C., Kopp U.A., Pajkert A., Behrens J.R., Leypoldt F., Wuerfel J.T., Ploner C.J., Prüss H., Paul F. (2015) Structural hippocampal damage in anti-NMDAR encephalitis. Biological Psychiatry S0006-3223(15)00149-3. IF 9.472

Leypoldt F., Höftberger R.*, Titulaer M.J.*, Armangue T., Gresa-Arribas N., Jahn H.,  Rostasy K.,  Schlumberger W., Meyer T., Wandinger K.P., Rosenfeld M., Graus F., Dalmau J. (2015) CXCL13 is a biomarker of response to treatment and outcome in anti-NMDA-receptor encephalitis. JAMA Neurol. 72(2):180-6. IF 7.685   *gleichberechtigte Autorenschaft

Planagumà J.*, Leypoldt F.*, Mannara F., Gutiérrez-Cuesta J.,  Martín-García E., Aguilar E., Titulaer M.J., Jain A., Balice-Gordon R., Lakadamyali M., Graus F., Maldonado R. and Dalmau J. (2015) Human N-Methyl-D-aspartate receptor antibodies alter memory and behavior in mice. Brain 138(Pt 1):94-109. IF: 9.915  *gleichberechtigte Autorenschaft

2014

Goldenberg N.A., Everett A.D., Graham D., Bernard T.J., Nowak-Göttl U. Proteomic and other mass spectrometry based "omics" biomarker discovery and validation in pediatric venous thromboembolism and arterial ischemic stroke: current state, unmet needs, and future directions. Proteomics Clin Appl. 2014 Dec;8(11-12):828-36. doi: 10.1002/prca.201400062. Review.

Nowak-Göttl U., Kenet G. Challenging aspects of managing hemostasis in adolescents. Acta Haematol. 2014;132(3-4):326-30. doi: 10.1159/000360237. Epub 2014 Sep 10. Review.

Limperger V., Klostermeier U.C., Kenet G., Holzhauer S., Alhenc Gelas M., Finckh U., Junker R., Heller C., Zieger B., Kurnik K., Knöfler R., Mesters R., Halimeh S., Nowak-Göttl U. Clinical and laboratory characteristics of children with venous thromboembolism and protein C-deficiency: an observational Israeli-German cohort study. Br J Haematol. 2014 Nov;167(3):385-93. doi: 10.1111/bjh.13039.

Limperger V., Franke A., Kenet G., Holzhauer S., Picard V., Junker R., Heller C.,Gille C., Manner D., Kurnik K., Knoefler R., Mesters R., Halimeh S., Nowak-Göttl U. Clinical and laboratory characteristics of paediatric and adolescent index cases with venous thromboembolism and antithrombin deficiency. An observational multicentre cohort study. Thromb Haemost. 2014 Sep 2;112(3):478-85. doi: 10.1160/TH14-02-0149.

Kenet G., Bidlingmaier C., Bogdanova N., Ettingshausen C.E., Goldenberg N., Gutsche S., Halimeh S., Holzhauer S., Kurnik K., Limperger V., Junker R., Nowak-Göttl U. Influence of factor 5 rs6025 and factor 2 rs1799963 mutation on inhibitor development in patients with hemophilia A--an Israeli-German multicenter database study. Thromb Res. 2014 Apr;133(4):544-9. doi: 10.1016/j.thromres.2014.01.005.

Minford A., Behnisch W., Brons P., David M., Gomez Gomez N., Hertfelder H.J., Kruempel A., Kurnik K., Mathias M., Molines Honrubia A., Monagle P., Morgan M., Nowak-Göttl U., Olivieri M. Subcutaneous protein C concentrate in the management of severe protein C deficiency--experience from 12 centres. Br J Haematol. 2014 Feb;164(3):414-21. doi: 10.1111/bjh.12640.

Stoll M., Rühle F., Nowak-Göttl U. Advances in understanding stroke risk in children--a geneticist's view. Br J Haematol. 2014 Mar;164(5):636-45. doi: 10.1111/bjh.12706.

Doss S*., Wandinger K.P.*, Hyman B., Panzer J., Synofzik M., Dickerson B., Mollenhauer B., Scherzer C.R., Ivinson A.J., Finke C., Schöls L., Müller vom Hagen J., Jahn H., Höltje M., Biswal B.B., Harms L. Ruprecht K., Buchert R., Höglinger G.U., Oertel W.H., Unger M.M., Priller J., Spruth E.J., Paul F., Meisel A., Lynch D., Dirnagl U., Endres M., Teegen B., Probst C., Komorowski L., Stöcker W., Dalmau J., Prüss H. (2014) High prevalence of NMDA receptor IgA/IgM antibodies in different types of dementia. Ann. Clin. Translat. Neurol. 1:, published online: 18 OCT 2014  *gleichberechtigte Autorenschaft

Leypoldt F., Höftberge, R., Titulaer M.J., Armangue T., Gresa-Arribas N., Jahn H., Rostasy K., Schlumberger W., Meyer T., Wandinger K.P., Graus F., Dalmau J. (2014) Investigations on CXCL13 in anti-NMDA receptor encephalitis, a potential biomarker of treatment response. JAMA Neurology, 72:180-186

Malter M.P., Frisch C., Schoene-Bake J.C., Helmstaedter C., Wandinger K.P., Stoecker W., Urbach H., Surges R., Elger C.E., Vincent A.V., Bien C.G. (2014) Outcome of limbic encephalitis with VGKC complex antibodies related to antigenic specificity. J. Neurol., 261:1695-1705.

Leypoldt F., Wandinger K.P. (2014) Paraneoplastic neurological syndromes. Clinical and Experimental Immunology, 175:336-348

Titulaer M.J., Höftberger R., Lizuka T., Leypoldt F., McCracken L., Cellucci T., Benson L.A., Shu H., Irioka T., Hirano M., Singh G., Calvo A.C., Kaida K., Morales P.S., Wirtz P.W., Yamamoto T., Reindl M., Rosenfeld M.R., Graus F., Saiz A., Dalmau J. (2014) Overlapping demyelinating syndromes and anti-NMDA receptor encephalitis. Ann Neurol. 75(3):411-28. IF: 11.193

Gresa-Arribas N., Titulaer M.J., Torrents A., Aguilar E., McCracken L., Leypoldt F., Gleichman A.J., Balice-Gordon R., Rosenfeld M.R., Lynch D., Graus F., Dalmau J. (2014) Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol 13(2):167-77. doi: 10.1016/S1474-4422(13)70282-5. IF: 23.930

Armangue T.*, Leypoldt F.*, Málaga I.,  Raspall-Chaure M., Marti I., Nichter C., Pugh J., Vicente-Rasoamalala M., Lafuente-Hidalgo M., Macaya A., Ke M., Titulaer M.J., Höftberger R., Sheriff H., Glaser C., Dalmau J. (2014) Herpes Simplex Virus Encephalitis is a Trigger of Brain Autoimmunity. Ann Neurol. 75(2):317-23. doi: 10.1002/ana.24083. IF 11.193

Bogner S., Bernreuther C., Matschke J., Barrera-Ocampo A., Sepulveda-Falla D., Leypoldt F., Magnus T., Haag F., Bergmann M., Brück W., Vogelgesang S., Glatzel M. (2014) Immune Activation in Amyloid-β-Related Angiitis Correlates with Decreased Parenchymal Amyloid-β Plaque Load. Neurodegener Dis 13(1):38-44. doi: 10.1159/000352020. IF 3.410

Neuromyelitis Optica Study Group (NEMOS). (2014) Update on the diagnosis and treatment of neuromyelitis optica. Recommendations of the Neuromyelitis Optica Study Group (NEMOS). J Neurol, 261:1-16

2013

Limperger V., Nowak-Göttl U. [Thromboembolisms in childhood and adolescence]. Kinderkrankenschwester. 2013 Oct;32(10):396-401.

Halimeh S., Bidlingmaier C., Heller C., Gutsche S., Holzhauer S., Kenet G., Kurnik K., Manner D., Iorio A., Nowak-Göttl U. Risk factors for high-titer inhibitor development in children with hemophilia A: results of a cohort study. Biomed Res  Int. 2013;2013:901975. doi: 10.1155/2013/901975. Epub 2013 Oct 2. PubMed PMID: 24199202

Nowak-Göttl U., Krümpel A., Russo A., Jansen M. Efficacy and safety of Wilate in paediatric VWD patients under 6 years of age - results of a prospective multicentre clinical study including recovery information. Haemophilia. 2013 Nov;19(6):887-92. doi: 10.1111/hae.12237.

Langer C., Tambyrayah B., Nowak-Göttl U. Testing for apolipoprotein(a) phenotype using isoelectric focusing and immunoblotting technique. Methods Mol Biol. 2013;992:407-12. doi: 10.1007/978-1-62703-339-8_33.

Nowak-Göttl U., Janssen V., Manner D., Kenet G. Venous thromboembolism in neonates and children--update 2013. Thromb Res. 2013 Jan;131 Suppl 1:S39-41. doi: 10.1016/S0049-3848(13)70019-7.

Dowling M.M., Hynan L.S., Lo W., Licht D.J., McClure C., Yager J.Y., Dlamini N., Kirkham F.J., Deveber G., Pavlakis S. International Paediatric Stroke Study Group. International Paediatric Stroke Study: stroke associated with cardiac disorders. Int J Stroke. 2013 Oct;8 Suppl A100:39-44. doi: 10.1111/j.1747-4949.2012.00925.x.

Tillack K., Naegele M., Haueis C., Schippling S., Wandinger K.P., Marti, R., Sospedra M. (2013) Gender differences in circulating levels of neutrophil extracellular traps in serum of multiple sclerosis patients. J. Neuroimmunol., Epub Jun 1

Jarius S., Martinez-Garcia P., Hernandez A.L., Brase J.C., Borowski K., Regula J.U., Meinck H.M., Stöcker W., Wildemann B., Wandinger K.P., (2013) Two new cases of anti-Ca (anti-ARHGAP26/GRAF) autoantibody-associated cerebellar ataxia. J. Neuroinflamm. 10:7 doi:10.1186/1742-2094-10-7

Hansen H.C., Klingbeil C., Dalmau J., L, W., Weißbrich B., Wandinger K.P. (2013) Persistent intrathecal antibody synthesis 15 years after recovering from anti-NMDAR encephalitis. JAMA Neurol., 70:117-119

Leypoldt F., Gelderblom M., Schöttle D., Hoffmann S., Wandinger K.P. (2013)  Recovery from severe frontotemporal dysfunction at 3 years after NMDA receptor antibody encephalitis. J. Clin. Neurosci., Epub Jan 10

Steiner J., Walter M., Glanz W., Sarnyai Z., Bernstein H.G., Vielhaber S., Kästner A., Skalej M., Jordan W., Schiltz K., Klingbeil C., Wandinger K.P. , Bogerts B., Stoecker W. (2013) Increased prevalence of diverse NMDA receptor antibodies in patients with an initial diagnosis of schizophrenia: Specific relevance of IgG NR1a antibodies for distinction from N-Methy-D-Aspartate glutamate receptor encephalitis. JAMA Psychiatry, Epub Jan 23

Leypoldt F., Wandinger,K.P., Bien C.G., Dalmau J. (2013) Autoimmune Encephalitis. European Neurological Review

Finke C., Kopp U.A., Scheel M., Pech L.M., Soemmer C., Schlichting J., Leypoldt F., Brandt A.U., Wuerfel J., Probst C., Ploner C.J., Prüss H., Paul F. (2013) Functional and structural brain changes in anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol 74(2):284-296. doi: 10.1002/ana.23932. IF 11.193

Neuromyelitis Optica Study Group (NEMOS). (2013) Contribution of spinal cord biopsy to diagnosis of aquaporin-4 antibody positive neuromyelitis optica spectrum disorder. Mult. Scler., Epub Nov 5

2012

Lambers M., Goldenberg N.A., Kenet G., Kirkham F.J., Manner D., Bernard T., Mesters R.M., Junker R., Stoll M., Nowak-Göttl U. Role of reduced ADAMTS13 in arterial ischemic stroke: a pediatric cohort study. Ann Neurol. 2013 Jan;73(1):58-64. doi: 10.1002/ana.23735. Epub 2012 Dec 7. PubMed PMID: 23225307

Arning A., Hiersche M., Witten A., Kurlemann G., Kurnik K., Manner D., Stoll M., Nowak-Göttl U. A genome-wide association study identifies a gene network of ADAMTS genes in the predisposition to pediatric stroke. Blood. 2012 Dec 20;120(26):5231-6. doi: 10.1182/blood-2012-07-442038.

Kenet G., Nowak-Göttl U. Venous thromboembolism in neonates and children. Best Pract Res Clin Haematol. 2012 Sep;25(3):333-44. doi: 10.1016/j.beha.2012.07.001.

Holzhauer S., Neil A., Goldenberg, Junker R., Heller C., Stoll M., Manner D., Mesters R., Krümpel A., Stach M., Nowak-Göttl U. Inherited thrombophilia in children with venous thromboembolism and the familial risk of thromboembolism: an observational study Blood blood-2012-01-405514; published ahead of print May 11, 2012, doi:10.1182/blood-2012-01-405514

Monagle P., Chan A.K., Goldenberg N.A., Ichord R.N., Journeycake J.M., Nowak-Göttl U., Vesely S.K.; American College of Chest Physicians. Antithrombotic therapy inneonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9thed: American College of Chest Physicians Evidence-Based Clinical PracticeGuidelines. Chest. 2012 Feb;141(2 Suppl):e737S-801S. PubMed PMID: 22315277;PubMed Central PMCID: PMC3278066.

Lebas A., Chabrier S., Fluss J., Gordon K., Kossorotoff M,. Nowak-Göttl U., de Vries L.S., Tardieu M. EPNS/SFNP guideline on the anticoagulant treatment of cerebralsinovenous thrombosis in children and neonates. Eur J Paediatr Neurol. 2012May;16(3):219-28. Epub 2012 Mar 16. PubMed PMID: 22425391.

Prüss H., Finke C., Höltje M., Hofmann J., Klingbeil C., Probst C., Borowski K., Ahnert-Hilger G., Harms L., Schwab J.M., Ploner C.J., Komorowski L., Stoecker W., Dalmau J., Wandinger K.P. (2012) NMDA receptor antibodies in herpes simplex encephalitis. Ann. Neurol. 72:902-911

Kraus P.D., Wolff D., Grauer O., Angstwurm K., Jarius S., Wandinger K.P., Holler E., Schulte-Mattler W., Kleiter I. (2012) Muscle cramps and neuropathies in patients with allogenic hematopoitic stem cell transplantation and graft-versus-host disease. PLoS  ONE,  Epub Sep 17

Haussleiter I.S., Emons B., Schaub M., Borowski K., Brüne M., Wandinger K.P., Juckel G. (2012) Investigation of antibodies against synaptic proteins in a cross-sectional cohort  of psychotic patients. Schizophr. Res., Epub May 28

von Glehn F., Jarius S., Penalva de Oliviera A.C., Brandao C.O., Faria, A.S., Damasceno A., Casseb J., Moraes A.S., Longhini A.L., Wandinger K.P., Damasceno B.P., Wildemann B., Santos L.M.B. (2012) Aquaporin-4 antibodies are not related to HTLV-1 associated myelopathy. PLoS ONE, 7:e39372

Prüss H., Höltje M., Maier N., Gomez A., Buchert R., Harms L., Ahnert-Hilger G., Schmitz D., Terborg C., Kopp U., Klingbeil C., Probst C., Kohler S., Schwab J.M., Stoecker W., Dalmau J., Wandinger K.P. (2012) IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment. Neurology, 78:1743-1753.

Jarius S., Paul F., Franciotta D., de Seze J., Münch C., Salvetti M., Ruprecht K., Liebetrau M., Wandinger K.P., Akman-Demir G., Melms A., Kristoferitsch W., Wildemann B. (2012) Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature. Multiple Sclerosis 18:1135-1143.

Jarius S., Wandinger K.P., Borowski K., Stoecker W., Wildemann B. (2012)  Antibodies to CV2/CRMP5 in neuromyelitis optica-like disease: a case associated with prostate cancer and review of the literature. Clin. Neurol. Neurosurg. 114:331-335.

Leypoldt F., Wandinger K.P., Voltz R. (2012) Neues bei paraneoplastischen Syndromen in der Neurologie. Akt.Neurologie, doi 10.1055/s-0032-1304305

Gelderblom M., Weymar A., Bernreuther C., Velden J., Arunachalam P., Steinbach K., Orthey E., Arumugam T.V., Leypoldt F., Simova O., Thom V., Friese M., Prinz I., Hölscher C., Glatzel M., Korn T., Gerloff C., Tolosa E., Magnus T. (2012) Neutralization of the IL-17 axis diminishes neutrophil invasion and protects from ischemic stroke. Blood 120:3793–3802. IF: 9.898

Leypoldt F., Buchert R., Kleiter I., Marienhagen J., Gelderblom M., Magnus T., Dalmau J., Gerloff C., Lewerenz J. (2012) FDG-PET in anti-N-methyl-D-aspartate receptor encephalitis: Distinct pattern of disease. JNNP 83(7):681-6. IF: 4.764

Gelderblom M.*, Leypoldt F.*, Lewerenz J., Birkenmayer G., Orozco D., Ludewig P., Thundyil J., Arumugam T.V., Gerloff C., Tolosa E., Maher P., Magnus T. (2012) The flavonoid fisetin attenuates postischemic immune cell infiltration, activation and infarct size after transient cerebral middle artery occlusion in mice. J Cereb Blood Flow Metab 32(5):835-43. IF: 5.008   *gleichberechtigte Autorenschaft

Radue E.W., O'Connor P., Polman C.H., Hohlfeld R., Calabresi P., Selmaj K., Mueller-Lenke N., Agoropoulou C., Holdbrook F., de Vera A., Zhang-Auberson L., Francis G., Burtin P., Kappos L.; FTY720 Research Evaluating Effects of Daily Oral  Therapy in Multiple Sclerosis (FREEDOMS) Study Group. (2012) Impact of fingolimod therapy on magnetic resonance imaging outcomes in patients with multiple sclerosis. Arch. Neurol. 69:1259-1269.

Devonshire V., Havradova E., Radue E.W., O’Connor P., Zhang-Auberson L., Agoropoulou C., Häring D.A., Francis G., Kappos L; FREEDOMS  study group. (2012) Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study. Lancet Neurol., 11:420-428.

Jarius S. et al.; Neuromyelitis optica study group (2012) Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients. J. Neuroinflamm. 9:14 doi:10.1186/1742-2094-9-14

2011

Bidlingmaier C., Kenet G., Kurnik K., Mathew P., Manner D., Mitchell L., Krümpel A,. Nowak-Göttl U. Safety and efficacy of low molecular weight heparins in children: a systematic review of the literature and meta-analysis of single-arm studies.Semin Thromb Hemost. 2011 Oct;37(7):814-25. Epub 2011 Dec 20. Review. PubMedPMID: 22187405.

Langer C., Tambyrayah B., Thedieck S., Nowak-Göttl U. Testing for lipoprotein(a) concentration and apolipoprotein(a) phenotypes: method standardization andpediatric reference values. Semin Thromb Hemost. 2011 Oct;37(7):810-3. Epub 2011 Dec 20. PubMed PMID: 22187404.

Kenet G., Aronis S., Berkun Y., Bonduel M., Chan A., Goldenberg N.A., Holzhauer S., Iorio A., Journeycake J., Junker R., Male C., Manco-Johnson M., Massicotte P., Mesters R., Monagle P., van Ommen H., Rafini L., Simioni P., Young G., Nowak-Göttl U. Impact ofpersistent antiphospholipid antibodies on risk of incident symptomatic thromboembolism in children: a systematic review and meta-analysis. Semin Thromb Hemost. 2011 Oct;37(7):802-9. Epub 2011 Dec 20. Review. PubMed PMID: 22187403.

Kenet G., Nowak-Göttl U. Hemostasis and thrombosis in pediatric patients:special issues and unique concerns. Semin Thromb Hemost. 2011 Oct;37(7):721-2.Epub 2011 Dec 20. PubMed PMID: 22187393.

Kirton A., Armstrong-Wells J., Chang T., Deveber G., Rivkin M.J., Hernandez M., Carpenter J., Yager J.Y., Lynch J.K., Ferriero D.M.; International Pediatric Stroke Study Investigators. Symptomatic neonatal arterial ischemic stroke: the International Pediatric Stroke Study. Pediatrics. 2011 Dec;128(6):e1402-10. Epub 2011 Nov 28. PubMed PMID: 22123886.

Kenet G., Nowak Gottl U. Thrombotic and bleeding disorders in perinatal medicine. Semin Fetal Neonatal Med. 2011 Dec;16(6):293. Epub 2011 Sep 1. PubMed PMID: 21889430.

Mitchell L..G, Goldenberg N.A., Male C., Kenet G., Monagle P., Nowak-Göttl U.; Perinatal and Paediatric Haemostasis Subcommittee of the SSC of the ISTH. Definition of clinical efficacy and safety outcomes for clinical trials in deep venous thrombosis and pulmonary embolism in children. J Thromb Haemost. 2011 Sep;9(9):1856-8. doi: 10.1111/j.1538-7836.2011.04433.x. PubMed PMID: 21884565.

Nowak-Göttl U., Kurnik K., Manner D., Kenet G.. Thrombophilia testing in neonates and infants with thrombosis. Semin Fetal Neonatal Med. 2011 Dec;16(6):345-8. Epub 2011 Aug 10. Review. PubMed PMID: 21835708.

Menascu S., Lotan A., Ben Zeev B., Nowak-Gottl U., Kenet G. Cerebral venous thrombosis in the mediterranean area in children. Mediterr J Hematol Infect Dis. 2011;3(1):e2011029. Epub 2011 Jul 8. PubMed PMID: 21869915; PubMed Central PMCID: PMC3152451.

Neuner B., von Mackensen S., Krümpel A., Manner D., Friefeld S., Nixdorf S., Frühwald M., deVeber G., Nowak-Göttl U. Health-related quality of life in children and adolescents with stroke, self-reports, and parent/proxies reports: cross-sectional investigation. Ann Neurol. 2011 Jul;70(1):70-8. doi: 10.1002/ana.22381. Epub 2011 Mar 18. PubMed PMID: 21425189.

Halimeh S., Krümpel A., Rott H., Bogdanova N., Budde U., Manner D., Faeser B., Mesters R., Nowak-Göttl U. Long-term secondary prophylaxis in children, adolescents and young adults with von Willebrand disease. Results of a cohort study. Thromb Haemost. 2011 Apr;105(4):597-604. Epub 2011 Feb 8. PubMed PMID: 21301780.

Nowak-Göttl U., Fiedler B., Huge A., Niederstadt T., Thedieck S., Seehafer T., Stoll M. Plasma glutathione peroxidase in pediatric stroke families. J Thromb Haemost. 2011 Jan;9(1):33-8. doi: 10.1111/j.1538-7836.2010.04103.x. PubMed PMID:  20946167.

Neuner B., Busch M.A., Singer S., Moons P., Wellmann J., Bauer U., Nowak-Göttl U., Hense H.W. Sense of Coherence as a Predictor of Quality of Life in Adolescents With Congenital Heart Defects: A Register-Based 1-Year Follow-Up Study. J Dev Behav Pediatr. 2011 Feb 15. [Epub ahead of print] PubMed PMID: 21325966.

Wandinger K.P., Klingbeil C., Gneiss C., Waters P., Dalmau J., Saschenbrecker S., Borowski K., Deisenhammer F., Vincent A., Probst C., Stoecker W. (2011) New serological markers for the differential diagnosis of autoimmune limbic encephalitis. J. Lab. Med., 35:329-342.

Zavada J., Nytrova P., Wandinger K.P., Jarius S., Svobodova R., Probst C., Peterova V., Tegzova D., Pavelka K., Vencovsky J. (2011) Seroprevalence and specificity  of NMO-IgG (anti-aquaporin 4 antibodies) in patients with neuropsychiatric systemic lupus erythematosus. Rheumatol Int., Epub Oct 29

Benzel F., Erdur H., Kohler S., Frentsch M., Thiel A., Harms L., Wandinger K.P., Rosche B. (2011) Immune monitoring of Trichuris suis egg therapy in multiple sclerosis. J. Helminthol., Epub Aug 15

Finke C., Prüß H., Scheel M., Ostendorf F., Harms L., Borowski K., Wandinger K.P., Ploner C.J. (2011) Anti-NMDA receptor antibodies in MELAS syndrome. J. Neurol., Epub Sep 6

Finke C., Kopp U.A., Prüss H., Dalmau J., Wandinger,K.P., Ploner C.J. (2011) Cognitive deficits following anti-NMDAR encephalitis. J. Neurol.  Neurosurg. Psychiatry, Epub Sep 20

Matsuya N., Komori M., Nomura K., Nakane S., Fukudome T., Goto H., Shiraishi H., Wandinger K.P., Matsuo H., Kondo T. (2011) Increased T cell immunity against aquaporin-4 and proteolipid protein in neuromyelitis optica. Int. Immunol., Epub July 27.

Jarius S., Paul F., Franciotta D., Ruprecht K., Ringelstein M., Bergamaschi R., Rommer P., Kleiter I., Stich O., Reuss R., Rauer S., Wandinger K.P., Melms A., Aktas O., Kristoferitsch W., Wildemann B. (2011) Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures. J.Neurol. Sci., Epub May 5.

Wandinger K.P., Saschenbrecker S., Steinhagen K., Scheper T., Meyer W., Bartelt U., Enders G. (2011) Diagnosis of recent primary rubella virus infections: Significance of glycoprotein-based IgM serology, IgG avidity and immunoblot analysis. J. Virol. Methods, Epub Apr 13.

Dörr J., Jarius S., Wildemann B., Ringelstein E.B., Schwindt W., Deppe M., Wandinger K.P., Promesberger J., Paul F., Kleffner I. (2011) The Susac Syndrome – An interdisciplinary Challenge. Nervenarzt, Epub Apr 10.

Jarius S., Jacobi C., de Seze J., Zephir H., Paul F., Franciotta D., Rommer P., Mader S., Kleiter I., Reindl M., Akman-Demir G., Seifert-Held T., Kristoferitsch W., Melms A., Wandinger K.P., Wildemann B. (2011) Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders. Multiple Sclerosis, Epub May 4.

Choe C.-U., Lardong K., Gelderblom M., Ludewig P., Leypoldt F., Koch-Nolte F., Gerloff C., Magnus T. (2011) CD38 exacerbates focal cytokine production, postischemic inflammation and brain injury after focal cerebral ischemia. PLoS ONE 6:e19046. IF: 4.092

2010

Nowak-Göttl U., Dietrich K., Schaffranek D., Eldin N.S., Yasui Y., Geisen C., Mitchell L.G. In pediatric patients, age has more impact on dosing of vitamin K antagonists than VKORC1 or CYP2C9 genotypes. Blood. 2010 Dec 23;116(26):6101-5. Epub 2010 Sep 10. PubMed PMID: 20833980.

Goerge T., Weishaupt C., Metze D., Nowak-Göttl U., Sunderkötter C., Steinhoff M., Schneider S.W. Livedoid vasculopathy in a pediatric patient with elevated lipoprotein(a) levels: prompt response to continuous low-molecular-weight heparin. Arch Dermatol. 2010 Aug;146(8):927-8. PubMed PMID: 20713839.

Trame M.N., Mitchell L., Krümpel A., Male C., Hempel G., Nowak-Göttl U. Population  pharmacokinetics of enoxaparin in infants, children and adolescents during secondary thromboembolic prophylaxis: a cohort study. J Thromb Haemost. 2010 Sep;8(9):1950-8. doi: 10.1111/j.1538-7836.2010.03964.x. PubMed PMID: 20586920.

Schlegel N., Bardet V., Kenet G., Muntean W., Zieger B., Nowak-Göttl U. Working Group on Standardisation in Perinatal and Pediatric Hemostasis. Diagnostic and therapeutic considerations on inherited platelet disorders in neonates and children. Klin Padiatr. 2010 May;222(3):209-14. Epub 2010 Jun 9. PubMed PMID: 20535670.

Halimeh S., Angelis G., Sander A., Edelbusch C., Rott H., Thedieck S., Mesters R., Schlegel N., Nowak-Göttl U. Multiplate whole blood impedance point of care aggregometry: preliminary reference values in healthy infants, children and adolescents. Klin Padiatr. 2010 May;222(3):158-63. Epub 2010 May 31. PubMed PMID: 20514620.

Stallmeyer B., Fenge H., Nowak-Göttl U., Schulze-Bahr E. Mutational spectrum in the cardiac transcription factor gene NKX2.5 (CSX) associated with congenital heart disease. Clin Genet. 2010 Dec;78(6):533-40. doi: 10.1111/j.1399-0004.2010.01422.x. PubMed PMID: 20456451.

Kenet G., Lütkhoff L.K., Albisetti M., Bernard T., Bonduel M., Brandao L,. Chabrier S., Chan A., deVeber G., Fiedler B., Fullerton H.J., Goldenberg N.A., Grabowski E., Günther G., Heller C., Holzhauer S., Iorio A., Journeycake J., Junker R., Kirkham F.J., Kurnik K., Lynch J.K., Male C., Manco-Johnson M., Mesters R., Monagle P., van Ommen C.H., Raffini L., Rostásy K., Simioni P., Sträter R.D., Young G., Nowak-Göttl U. Impact of thrombophilia on risk of arterial ischemic stroke or cerebral sinovenous thrombosis in neonates and children: a systematic review and meta-analysis of observational studies. Circulation. 2010 Apr 27;121(16):1838-47. Epub 2010 Apr 12. Review. PubMed PMID: 20385928.

Iorio A., Halimeh S., Holzhauer S., Goldenberg N., Marchesini E., Marcucci M., Young G., Bidlingmaier C., Brandao L.R., Ettingshausen C.E., Gringeri A., Kenet G., Knöfler R., Kreuz W., Kurnik K., Manner D., Santagostino E., Mannucci P.M., Nowak-Göttl U. Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived or recombinant factor VIII concentrates: a systematic review. J Thromb Haemost. 2010 Jun;8(6):1256-65. Epub 2010 Mar 17. Review. PubMed PMID: 20345722.

Mitchell L., Lambers M., Flege S., Kenet G., Li-Thiao-Te V., Holzhauer S.,.Bidlingmaier C., Frühwald M.C., Heller C., Schmidt W., Pautard B., Nowak-Göttl U. Validation of a predictive model for identifying an increased risk for thromboembolism in children with acute lymphoblastic leukemia: results of a multicenter cohort study. Blood. 2010 Jun 17;115(24):4999-5004. Epub 2010 Mar 25. PubMed PMID: 20339086; PubMed Central PMCID: PMC2890143.

Jordan L.C., Rafay M.F., Smith S.E., Askalan R., Zamel K.M., deVeber G., Ashwal S.; International Pediatric Stroke Study Group. Antithrombotic treatment in neonatal cerebral sinovenous thrombosis: results of the International Pediatric Stroke Study. J Pediatr. 2010 May;156(5):704-10, 710.e1-710.e2. Epub 2010 Feb 10. PubMed PMID: 20149389; PubMed Central PMCID: PMC2854210.

Goldenberg N.A., Donadini M.P., Kahn S.R., Crowther M., Kenet G., Nowak-Göttl U., Manco-Johnson M.J.. Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors. Haematologica. 2010 Nov;95(11):1952-9. Epub 2010 Jun 30. Review. PubMed PMID: 20595095; PubMed Central PMCID: PMC2966919.

Jarius S.*, Wandinger K.P.*, Platzer S., Wildemann B. (2010) Homology between Klebsiella pneumoniae and human aquaporin-4: no evidence of cross-reactivity in in neuromyelitis optica. A study on 114 patients. J. Neurol., Epub Dec 2     *gleichberechtigte Autorenschaft

Jarius S., Franciotta D., Paul F., Ruprecht K., Bergamaschi R., Rommer P.S., Reuss R., Probst C., Kristoferitsch W., Wandinger K.P.*, Wildemann B*. (2010) Cerebrospinal fluid antibodies to      aquaporin-4 in neuromyelitis optica and related disorders: frequency,      origin, and diagnostic relevance. J. Neuroinflamm., 7:52    *gleichberechtigte Autorenschaft

Prüss H., Dalmau J., Harms L., Höltje M., Ahnert-Hilger G., Borowski K., Stoecker W., Wandinger K.P. (2010) Retrospective analysis of anti-glutamate receptor (type NMDA)      antibodies in patients with encephalitis of unknown origin. Neurology, 75:1735-1739

Wandinger, K.P., Saschenbrecker S., Stoecker W., Dalmau J. (2010) Anti-NMDA-receptor encephalitis: A severe, multistage, treatable disorder presenting with psychosis. J. Neuroimmunol., doi:10.1016/j.jneuroim.2010.09.012

Wandinger K.P., Stangel M., Witte T.,Venables P., Charles P., Jarius S., Wildemann B., Probst C., Iking-Konert C., Schneider M. (2010) Autoantibodies against aquaporin-4  in patients with neuropsychiatric SLE and primary Sjögren´s syndrome. Arthritis Rheum., doi: 10.1002/art.27337

Jarius S., Wandinger K.P., Horn S., Heuer H., Wildemann B. (2010) A new Purkinje cell antibody (anti-Ca) associated with subacute cerebellar ataxia: immunological      characterization. J. Neuroinflamm., Epub Mar 12;7(1):21

Scheper T., Saschenbrecker S., Steinhagen K., Sauerbrei A., Suer W., Meyer W., Schlumberger W., Wandinger K.P. (2010) The glycoproteins C and G are equivalent target antigens for the determination of herpes simplex virus type 1-specific antibodies. J. Virol. Methods, doi:10.1016/j.jviromet.2010.02.015

Jarius S., Franciotta D., Bergamaschi R., Wildemann B., Wandinger K.P. (2010) Immunoglobulin M antibodies to aquaporin-4 in neuromyelitis optica and related disorders. Clin. Chem. Lab. Med., doi: 10.1515/CCLM.2010.127

Jarius S., Warth A., Wandinger K.P., Schnabel P.A., Hoffmann H., Wildemann B., Muley T. (2010) Antibodies to aquaporin-4 in non-small cell lung cancer: a study on fifty patients. Neurol. Sci., Epub May 27

Prüss H., Dalmau J., Arolt V., Wandinger K.P. (2010) Anti-NMDA receptor encephalitis: An interdisciplinary clinical picture. Nervenarzt, doi: 10.1007/s00115-009-2908-9

Jarius S., Probst C., Borowski K., Franciotta D., Wildemann B., Stoecker W., Wandinger K.P. (2010) Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen. J. Neurol. Sci., doi: 10.1016/j.jns.2010.01.002

Bannas P., Weber C., Derlin T., Lambert J., Leypoldt F., Adam G., Mester J., Klutmann S. (2010) 18F-FDG-PET/CT in the diagnosis of paraneoplastic neurological syndromes: a retrospective analysis. European Radiology 20:923–930. IF: 3.222

Wynn D., Kaufman M., Montalban X., Voller T., Simon J., Elkins J., o’Neill G., Neyer L., Sheridan J., Wang C., Fong A., Rose J.W.; CHOICE investigators. (2010) Daclizumab in      active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta. Lancet Neurology, 9:381-390.

Kappos L., Radue E.W., O’Connor P., Polman C., Hohlfeld R., Calabresi P., Selmaj K., Agoropoulou C., Leyk M., Zhang-Auberson L., Burtin P.; FREEDOMS Study Group. (2010) A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N. Engl. J. Med., 362:387-401.